M. De Ley

Recent developments in quantification methods for metallothionein.

M. Dabrio, A. Rodrı́guez, G. Bordin, 2002, Journal of inorganic biochemistry.

Bcl-2 expression in human melanocytes and melanocytic tumors.

M. De Ley, J. J. van den Oord, C. de Wolf‐Peeters, 1994, The American journal of pathology.

Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16.

M. De Ley, A. Bernard, I. Dierynck, 1995, American journal of respiratory cell and molecular biology.

Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent.

M. De Ley, P. Declerck, H. Deckmyn, 1993, Blood.

Serum-induced expression of metallothionein isoforms in K-562 cells.

M. De Ley, Kelly Kuppens, M. de Ley, 2006, Biochemical and biophysical research communications.

Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.

M. De Ley, J. van Beeumen, A. Billiau, 1988, Journal of immunology.

Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1

M. De Ley, G. Opdenakker, J. Beeumen, 1985, Nature.

The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor.

M. De Ley, C. Dinarello, J. Van Snick, 1987, Journal of immunology.